source
- Arbitration panel rules Prime Medicine did not breach Beam deal over AATD therapyAn arbitration panel has ruled that Prime Medicine did not violate its 2019 collaboration agreement with Beam Therapeutics by advancing a treatment for alpha‑1 antitrypsin deficiency (AATD). The de…
- FDA grants accelerated approval to Vera Therapeutics' Trutakna for IgA nephropathyThe FDA has granted accelerated approval to Trutakna (formerly known as atacicept) from Vera Therapeutics for adult patients with IgA nephropathy, a chronic kidney disease that can progress to rena…